This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Merck + Co., Inc.. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Steve W. Ludmerer: Innovator in GABA-Gated Chloride Channel Polypeptides
Introduction
Steve W. Ludmerer is an accomplished inventor based in North Wales, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides and nucleic acids related to GABA-gated chloride channels. His work is crucial in addressing tick infestations, which are associated with various diseases.
Latest Patents
Steve W. Ludmerer holds 1 patent that focuses on GABA-gated chloride channel polypeptides and nucleic acids. This invention aims to provide compounds that can prevent or treat tick infestations, showcasing the practical applications of his research in public health.
Career Highlights
Steve is currently employed at Merck & Co., Inc., a leading global healthcare company. His role at Merck allows him to collaborate with other experts in the field and contribute to innovative solutions in biotechnology.
Collaborations
Throughout his career, Steve has worked alongside talented colleagues, including Yingcong Zheng and Doris F. Cully. These collaborations have enhanced the research and development efforts in their respective projects.
Conclusion
Steve W. Ludmerer is a notable inventor whose work in GABA-gated chloride channel polypeptides has the potential to impact the prevention and treatment of tick-related diseases. His contributions to biotechnology continue to advance the field and improve public health outcomes.